Anne Wojcicki new offer to take 23Andme Private for $ 74.7 million

23Andme Executive Director Anne Wojcicki and New Mountain Capital filed a proposal to attract a private genetic test company, the Friday said on Friday submission with an American commission for securities.

Wojcicki and New Mountain have offered the acquisition of all 23Andme uninisulated shares in cash for $ 2.53 per share, or at a capital of about $ 74.7 million. The company’s shares closed to $ 2.42 on Friday with a market limit of about $ 65 million.

The offer comes after a turbulent year for 23Andme and the section lost more than 80% of its value in 2024. In January, the company announced Research plans Strategic alternativeswhich could include the sale of companies or its property, restructuring or business combination.

23Andme has a special committee of independent directors to assess potential pathways forward. In October, the company appointed three new independent director in its committee after all seven of its previous directors abruptly resigned the previous month. The special committee must approve the proposal of Wojcickija and New Mountain.

“We believe that our proposal provides a convincing value and immediate liquidity of the company’s public shareholders,” Wojcicki and Matthew Holt, General Director and President of Private Capital on New Mountain wrote on Thursday, in a letter to a special committee on Thursday.

Wojcicki previously filed a proposal Take the company privately for 40 cents per share in July but either rejected A special committee, partly because the members said that he lacked dedicated financing and did not provide a premium at the time.

Wojcicki and New Mountain are willing to ensure that the financing of debt funding for the 23AndME business financing until the closure of the transaction is provided, according to the application. A new mountain based in New York and has $ 55 billion in property under management, according to it website.

23Andme refused to comment.

WATCH: Rise and fall 23andme